Outcomes of primary coronary angioplasty and angioplasty after initial thrombolysis in the treatment of 374 consecutive patients with acute myocardial infarction

In patients with acute myocardial infarction (MI), the efficacy of thrombolysis is low. Angioplasty after failed thrombolysis (rescue percutaneous coronary angioplasty [PTCA]) has been associated with an increase in the incidence of inhospital complications. It has been proposed that these complicat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The American heart journal 2003-05, Vol.145 (5), p.855-861
Hauptverfasser: Poloński, Lech, Gåsior, Mariusz, Wasilewski, Jarosław, Wilczek, Krzysztof, Wnęk, Andrzej, Adamowicz-Czoch, MD, E.lżbieta, Sikora, Jacek, Lekston, Andrzej, Zębik, Tadeusz, Gierlotka, Marek, Wojnar, Rafał, Szkodziński, Janusz, Kondys, Marek, Szyguła-Jurkiewicz, B.ożena, Wołk, Robert, Zembala, Marian
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 861
container_issue 5
container_start_page 855
container_title The American heart journal
container_volume 145
creator Poloński, Lech
Gåsior, Mariusz
Wasilewski, Jarosław
Wilczek, Krzysztof
Wnęk, Andrzej
Adamowicz-Czoch, MD, E.lżbieta
Sikora, Jacek
Lekston, Andrzej
Zębik, Tadeusz
Gierlotka, Marek
Wojnar, Rafał
Szkodziński, Janusz
Kondys, Marek
Szyguła-Jurkiewicz, B.ożena
Wołk, Robert
Zembala, Marian
description In patients with acute myocardial infarction (MI), the efficacy of thrombolysis is low. Angioplasty after failed thrombolysis (rescue percutaneous coronary angioplasty [PTCA]) has been associated with an increase in the incidence of inhospital complications. It has been proposed that these complications result from the procedure itself. Thus, the aim of this study was to compare the efficacy, inhospital complications, and mortality rate of patients with MI who are treated with primary PTCA and PTCA after initial thrombolysis (rescue or immediate rescue) in an experienced clinical center specializing in percutaneous coronary interventions. The study group consisted of consecutive patients with MI treated with primary PTCA (n = 195) or PTCA after initial thrombolysis (n = 179). The study was performed in a referral center with a 24-hour catheter-laboratory service. The success rate of the procedure was 90.5% and 88.2% in the PTCA after initial thrombolysis group and primary PTCA group, respectively. The groups did not differ in the frequency of reocclusion, emergency surgical revascularization (coronary artery bypass grafting), or stroke. In patients without cardiogenic shock, the inhospital mortality rates were 3.2% and 0.6% in the rescue and immediate rescue group and primary PTCA group, respectively (not significant). In a subgroup of patients with cardiogenic shock, the mortality rate was 36.0% in the initial thrombolysis PTCA group and 30.8% in the primary PTCA group. However, after successful PTCA in this subgroup, the mortality rate dropped to 18% and 10%, respectively. After initial thrombolysis, PTCA is safe, effective, and likely to restore grade 3 Thrombolysis In Myocardial Infarction flow in about 90% of patients. When available, immediate rescue PTCA should be performed in all patients, including patients with cardiogenic shock.
doi_str_mv 10.1016/S0002-8703(02)94823-4
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1504534033</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0002870302948234</els_id><sourcerecordid>3237754241</sourcerecordid><originalsourceid>FETCH-LOGICAL-c334t-473e5c5d18c9a436684e84687f98e1d1b406fe725153d34834331e074cc2712d3</originalsourceid><addsrcrecordid>eNqFkc1u1DAUhS0EotPCI4AsIaSyCNjxje1ZVajiT6rUBbC2PPYNdZXEg-0UzePwpjidiIoVq_vjz8fWOYS84OwtZ1y--8oYaxutmDhn7Zst6FY08IhsONuqRiqAx2TzFzkhpznf1lG2Wj4lJ7xVcmE25Pf1XFwcMdPY030Ko00H6mKK09LY6UeI-8HmsvT-37kvmGiYQgl2oOUmxXEXh0MOuS7rjLQktGXEqSzaQkHVnTK6uYQ7pHtbQj3K9FcoN9TWLdLxEJ1NftELU2-TKyFOz8iT3g4Zn6_1jHz_-OHb5efm6vrTl8v3V40TAkoDSmDnOs-121oQUmpADVKrfquRe74DJntUbcc74QVoAUJwZAqcaxVvvTgjr466-xR_zpiLuY1zmuqThncMOgFMiEp1R8qlmHPC3qymGc7MEoy5D8Ysrpta74MxUO-9XNXn3Yj-4daaRAVer4DNzg59spML-YEDzZXWrHIXRw6rF3cBk8muGunQh4SuGB_Df77yB8iDrMw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1504534033</pqid></control><display><type>article</type><title>Outcomes of primary coronary angioplasty and angioplasty after initial thrombolysis in the treatment of 374 consecutive patients with acute myocardial infarction</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><source>ProQuest Central UK/Ireland</source><creator>Poloński, Lech ; Gåsior, Mariusz ; Wasilewski, Jarosław ; Wilczek, Krzysztof ; Wnęk, Andrzej ; Adamowicz-Czoch, MD, E.lżbieta ; Sikora, Jacek ; Lekston, Andrzej ; Zębik, Tadeusz ; Gierlotka, Marek ; Wojnar, Rafał ; Szkodziński, Janusz ; Kondys, Marek ; Szyguła-Jurkiewicz, B.ożena ; Wołk, Robert ; Zembala, Marian</creator><creatorcontrib>Poloński, Lech ; Gåsior, Mariusz ; Wasilewski, Jarosław ; Wilczek, Krzysztof ; Wnęk, Andrzej ; Adamowicz-Czoch, MD, E.lżbieta ; Sikora, Jacek ; Lekston, Andrzej ; Zębik, Tadeusz ; Gierlotka, Marek ; Wojnar, Rafał ; Szkodziński, Janusz ; Kondys, Marek ; Szyguła-Jurkiewicz, B.ożena ; Wołk, Robert ; Zembala, Marian</creatorcontrib><description>In patients with acute myocardial infarction (MI), the efficacy of thrombolysis is low. Angioplasty after failed thrombolysis (rescue percutaneous coronary angioplasty [PTCA]) has been associated with an increase in the incidence of inhospital complications. It has been proposed that these complications result from the procedure itself. Thus, the aim of this study was to compare the efficacy, inhospital complications, and mortality rate of patients with MI who are treated with primary PTCA and PTCA after initial thrombolysis (rescue or immediate rescue) in an experienced clinical center specializing in percutaneous coronary interventions. The study group consisted of consecutive patients with MI treated with primary PTCA (n = 195) or PTCA after initial thrombolysis (n = 179). The study was performed in a referral center with a 24-hour catheter-laboratory service. The success rate of the procedure was 90.5% and 88.2% in the PTCA after initial thrombolysis group and primary PTCA group, respectively. The groups did not differ in the frequency of reocclusion, emergency surgical revascularization (coronary artery bypass grafting), or stroke. In patients without cardiogenic shock, the inhospital mortality rates were 3.2% and 0.6% in the rescue and immediate rescue group and primary PTCA group, respectively (not significant). In a subgroup of patients with cardiogenic shock, the mortality rate was 36.0% in the initial thrombolysis PTCA group and 30.8% in the primary PTCA group. However, after successful PTCA in this subgroup, the mortality rate dropped to 18% and 10%, respectively. After initial thrombolysis, PTCA is safe, effective, and likely to restore grade 3 Thrombolysis In Myocardial Infarction flow in about 90% of patients. When available, immediate rescue PTCA should be performed in all patients, including patients with cardiogenic shock.</description><identifier>ISSN: 0002-8703</identifier><identifier>EISSN: 1097-6744</identifier><identifier>DOI: 10.1016/S0002-8703(02)94823-4</identifier><identifier>PMID: 12766744</identifier><identifier>CODEN: AHJOA2</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Angioplasty ; Angioplasty, Balloon, Coronary - adverse effects ; Angioplasty, Balloon, Coronary - mortality ; Biological and medical sciences ; Cardiology ; Cardiology. Vascular system ; Coronary heart disease ; Coronary vessels ; Female ; Fibrinolytic Agents - therapeutic use ; Heart ; Heart attacks ; Hospital Mortality ; Humans ; Male ; Medical sciences ; Middle Aged ; Mortality ; Myocardial Infarction - mortality ; Myocardial Infarction - therapy ; Retrospective Studies ; Salvage Therapy ; Shock, Cardiogenic - mortality ; Thrombolytic Therapy - adverse effects ; Thrombolytic Therapy - methods ; Treatment Outcome</subject><ispartof>The American heart journal, 2003-05, Vol.145 (5), p.855-861</ispartof><rights>2003 Mosby, Inc.</rights><rights>2003 INIST-CNRS</rights><rights>Copyright Elsevier Limited May 2003</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c334t-473e5c5d18c9a436684e84687f98e1d1b406fe725153d34834331e074cc2712d3</citedby><cites>FETCH-LOGICAL-c334t-473e5c5d18c9a436684e84687f98e1d1b406fe725153d34834331e074cc2712d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/1504534033?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995,64385,64389,72469</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=14817880$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12766744$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Poloński, Lech</creatorcontrib><creatorcontrib>Gåsior, Mariusz</creatorcontrib><creatorcontrib>Wasilewski, Jarosław</creatorcontrib><creatorcontrib>Wilczek, Krzysztof</creatorcontrib><creatorcontrib>Wnęk, Andrzej</creatorcontrib><creatorcontrib>Adamowicz-Czoch, MD, E.lżbieta</creatorcontrib><creatorcontrib>Sikora, Jacek</creatorcontrib><creatorcontrib>Lekston, Andrzej</creatorcontrib><creatorcontrib>Zębik, Tadeusz</creatorcontrib><creatorcontrib>Gierlotka, Marek</creatorcontrib><creatorcontrib>Wojnar, Rafał</creatorcontrib><creatorcontrib>Szkodziński, Janusz</creatorcontrib><creatorcontrib>Kondys, Marek</creatorcontrib><creatorcontrib>Szyguła-Jurkiewicz, B.ożena</creatorcontrib><creatorcontrib>Wołk, Robert</creatorcontrib><creatorcontrib>Zembala, Marian</creatorcontrib><title>Outcomes of primary coronary angioplasty and angioplasty after initial thrombolysis in the treatment of 374 consecutive patients with acute myocardial infarction</title><title>The American heart journal</title><addtitle>Am Heart J</addtitle><description>In patients with acute myocardial infarction (MI), the efficacy of thrombolysis is low. Angioplasty after failed thrombolysis (rescue percutaneous coronary angioplasty [PTCA]) has been associated with an increase in the incidence of inhospital complications. It has been proposed that these complications result from the procedure itself. Thus, the aim of this study was to compare the efficacy, inhospital complications, and mortality rate of patients with MI who are treated with primary PTCA and PTCA after initial thrombolysis (rescue or immediate rescue) in an experienced clinical center specializing in percutaneous coronary interventions. The study group consisted of consecutive patients with MI treated with primary PTCA (n = 195) or PTCA after initial thrombolysis (n = 179). The study was performed in a referral center with a 24-hour catheter-laboratory service. The success rate of the procedure was 90.5% and 88.2% in the PTCA after initial thrombolysis group and primary PTCA group, respectively. The groups did not differ in the frequency of reocclusion, emergency surgical revascularization (coronary artery bypass grafting), or stroke. In patients without cardiogenic shock, the inhospital mortality rates were 3.2% and 0.6% in the rescue and immediate rescue group and primary PTCA group, respectively (not significant). In a subgroup of patients with cardiogenic shock, the mortality rate was 36.0% in the initial thrombolysis PTCA group and 30.8% in the primary PTCA group. However, after successful PTCA in this subgroup, the mortality rate dropped to 18% and 10%, respectively. After initial thrombolysis, PTCA is safe, effective, and likely to restore grade 3 Thrombolysis In Myocardial Infarction flow in about 90% of patients. When available, immediate rescue PTCA should be performed in all patients, including patients with cardiogenic shock.</description><subject>Angioplasty</subject><subject>Angioplasty, Balloon, Coronary - adverse effects</subject><subject>Angioplasty, Balloon, Coronary - mortality</subject><subject>Biological and medical sciences</subject><subject>Cardiology</subject><subject>Cardiology. Vascular system</subject><subject>Coronary heart disease</subject><subject>Coronary vessels</subject><subject>Female</subject><subject>Fibrinolytic Agents - therapeutic use</subject><subject>Heart</subject><subject>Heart attacks</subject><subject>Hospital Mortality</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Mortality</subject><subject>Myocardial Infarction - mortality</subject><subject>Myocardial Infarction - therapy</subject><subject>Retrospective Studies</subject><subject>Salvage Therapy</subject><subject>Shock, Cardiogenic - mortality</subject><subject>Thrombolytic Therapy - adverse effects</subject><subject>Thrombolytic Therapy - methods</subject><subject>Treatment Outcome</subject><issn>0002-8703</issn><issn>1097-6744</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFkc1u1DAUhS0EotPCI4AsIaSyCNjxje1ZVajiT6rUBbC2PPYNdZXEg-0UzePwpjidiIoVq_vjz8fWOYS84OwtZ1y--8oYaxutmDhn7Zst6FY08IhsONuqRiqAx2TzFzkhpznf1lG2Wj4lJ7xVcmE25Pf1XFwcMdPY030Ko00H6mKK09LY6UeI-8HmsvT-37kvmGiYQgl2oOUmxXEXh0MOuS7rjLQktGXEqSzaQkHVnTK6uYQ7pHtbQj3K9FcoN9TWLdLxEJ1NftELU2-TKyFOz8iT3g4Zn6_1jHz_-OHb5efm6vrTl8v3V40TAkoDSmDnOs-121oQUmpADVKrfquRe74DJntUbcc74QVoAUJwZAqcaxVvvTgjr466-xR_zpiLuY1zmuqThncMOgFMiEp1R8qlmHPC3qymGc7MEoy5D8Ysrpta74MxUO-9XNXn3Yj-4daaRAVer4DNzg59spML-YEDzZXWrHIXRw6rF3cBk8muGunQh4SuGB_Df77yB8iDrMw</recordid><startdate>20030501</startdate><enddate>20030501</enddate><creator>Poloński, Lech</creator><creator>Gåsior, Mariusz</creator><creator>Wasilewski, Jarosław</creator><creator>Wilczek, Krzysztof</creator><creator>Wnęk, Andrzej</creator><creator>Adamowicz-Czoch, MD, E.lżbieta</creator><creator>Sikora, Jacek</creator><creator>Lekston, Andrzej</creator><creator>Zębik, Tadeusz</creator><creator>Gierlotka, Marek</creator><creator>Wojnar, Rafał</creator><creator>Szkodziński, Janusz</creator><creator>Kondys, Marek</creator><creator>Szyguła-Jurkiewicz, B.ożena</creator><creator>Wołk, Robert</creator><creator>Zembala, Marian</creator><general>Elsevier Inc</general><general>Elsevier</general><general>Elsevier Limited</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QO</scope><scope>7RV</scope><scope>7TS</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope></search><sort><creationdate>20030501</creationdate><title>Outcomes of primary coronary angioplasty and angioplasty after initial thrombolysis in the treatment of 374 consecutive patients with acute myocardial infarction</title><author>Poloński, Lech ; Gåsior, Mariusz ; Wasilewski, Jarosław ; Wilczek, Krzysztof ; Wnęk, Andrzej ; Adamowicz-Czoch, MD, E.lżbieta ; Sikora, Jacek ; Lekston, Andrzej ; Zębik, Tadeusz ; Gierlotka, Marek ; Wojnar, Rafał ; Szkodziński, Janusz ; Kondys, Marek ; Szyguła-Jurkiewicz, B.ożena ; Wołk, Robert ; Zembala, Marian</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c334t-473e5c5d18c9a436684e84687f98e1d1b406fe725153d34834331e074cc2712d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Angioplasty</topic><topic>Angioplasty, Balloon, Coronary - adverse effects</topic><topic>Angioplasty, Balloon, Coronary - mortality</topic><topic>Biological and medical sciences</topic><topic>Cardiology</topic><topic>Cardiology. Vascular system</topic><topic>Coronary heart disease</topic><topic>Coronary vessels</topic><topic>Female</topic><topic>Fibrinolytic Agents - therapeutic use</topic><topic>Heart</topic><topic>Heart attacks</topic><topic>Hospital Mortality</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Mortality</topic><topic>Myocardial Infarction - mortality</topic><topic>Myocardial Infarction - therapy</topic><topic>Retrospective Studies</topic><topic>Salvage Therapy</topic><topic>Shock, Cardiogenic - mortality</topic><topic>Thrombolytic Therapy - adverse effects</topic><topic>Thrombolytic Therapy - methods</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Poloński, Lech</creatorcontrib><creatorcontrib>Gåsior, Mariusz</creatorcontrib><creatorcontrib>Wasilewski, Jarosław</creatorcontrib><creatorcontrib>Wilczek, Krzysztof</creatorcontrib><creatorcontrib>Wnęk, Andrzej</creatorcontrib><creatorcontrib>Adamowicz-Czoch, MD, E.lżbieta</creatorcontrib><creatorcontrib>Sikora, Jacek</creatorcontrib><creatorcontrib>Lekston, Andrzej</creatorcontrib><creatorcontrib>Zębik, Tadeusz</creatorcontrib><creatorcontrib>Gierlotka, Marek</creatorcontrib><creatorcontrib>Wojnar, Rafał</creatorcontrib><creatorcontrib>Szkodziński, Janusz</creatorcontrib><creatorcontrib>Kondys, Marek</creatorcontrib><creatorcontrib>Szyguła-Jurkiewicz, B.ożena</creatorcontrib><creatorcontrib>Wołk, Robert</creatorcontrib><creatorcontrib>Zembala, Marian</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Physical Education Index</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><jtitle>The American heart journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Poloński, Lech</au><au>Gåsior, Mariusz</au><au>Wasilewski, Jarosław</au><au>Wilczek, Krzysztof</au><au>Wnęk, Andrzej</au><au>Adamowicz-Czoch, MD, E.lżbieta</au><au>Sikora, Jacek</au><au>Lekston, Andrzej</au><au>Zębik, Tadeusz</au><au>Gierlotka, Marek</au><au>Wojnar, Rafał</au><au>Szkodziński, Janusz</au><au>Kondys, Marek</au><au>Szyguła-Jurkiewicz, B.ożena</au><au>Wołk, Robert</au><au>Zembala, Marian</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Outcomes of primary coronary angioplasty and angioplasty after initial thrombolysis in the treatment of 374 consecutive patients with acute myocardial infarction</atitle><jtitle>The American heart journal</jtitle><addtitle>Am Heart J</addtitle><date>2003-05-01</date><risdate>2003</risdate><volume>145</volume><issue>5</issue><spage>855</spage><epage>861</epage><pages>855-861</pages><issn>0002-8703</issn><eissn>1097-6744</eissn><coden>AHJOA2</coden><abstract>In patients with acute myocardial infarction (MI), the efficacy of thrombolysis is low. Angioplasty after failed thrombolysis (rescue percutaneous coronary angioplasty [PTCA]) has been associated with an increase in the incidence of inhospital complications. It has been proposed that these complications result from the procedure itself. Thus, the aim of this study was to compare the efficacy, inhospital complications, and mortality rate of patients with MI who are treated with primary PTCA and PTCA after initial thrombolysis (rescue or immediate rescue) in an experienced clinical center specializing in percutaneous coronary interventions. The study group consisted of consecutive patients with MI treated with primary PTCA (n = 195) or PTCA after initial thrombolysis (n = 179). The study was performed in a referral center with a 24-hour catheter-laboratory service. The success rate of the procedure was 90.5% and 88.2% in the PTCA after initial thrombolysis group and primary PTCA group, respectively. The groups did not differ in the frequency of reocclusion, emergency surgical revascularization (coronary artery bypass grafting), or stroke. In patients without cardiogenic shock, the inhospital mortality rates were 3.2% and 0.6% in the rescue and immediate rescue group and primary PTCA group, respectively (not significant). In a subgroup of patients with cardiogenic shock, the mortality rate was 36.0% in the initial thrombolysis PTCA group and 30.8% in the primary PTCA group. However, after successful PTCA in this subgroup, the mortality rate dropped to 18% and 10%, respectively. After initial thrombolysis, PTCA is safe, effective, and likely to restore grade 3 Thrombolysis In Myocardial Infarction flow in about 90% of patients. When available, immediate rescue PTCA should be performed in all patients, including patients with cardiogenic shock.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>12766744</pmid><doi>10.1016/S0002-8703(02)94823-4</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0002-8703
ispartof The American heart journal, 2003-05, Vol.145 (5), p.855-861
issn 0002-8703
1097-6744
language eng
recordid cdi_proquest_journals_1504534033
source MEDLINE; Elsevier ScienceDirect Journals Complete; ProQuest Central UK/Ireland
subjects Angioplasty
Angioplasty, Balloon, Coronary - adverse effects
Angioplasty, Balloon, Coronary - mortality
Biological and medical sciences
Cardiology
Cardiology. Vascular system
Coronary heart disease
Coronary vessels
Female
Fibrinolytic Agents - therapeutic use
Heart
Heart attacks
Hospital Mortality
Humans
Male
Medical sciences
Middle Aged
Mortality
Myocardial Infarction - mortality
Myocardial Infarction - therapy
Retrospective Studies
Salvage Therapy
Shock, Cardiogenic - mortality
Thrombolytic Therapy - adverse effects
Thrombolytic Therapy - methods
Treatment Outcome
title Outcomes of primary coronary angioplasty and angioplasty after initial thrombolysis in the treatment of 374 consecutive patients with acute myocardial infarction
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T23%3A43%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Outcomes%20of%20primary%20coronary%20angioplasty%20and%20angioplasty%20after%20initial%20thrombolysis%20in%20the%20treatment%20of%20374%20consecutive%20patients%20with%20acute%20myocardial%20infarction&rft.jtitle=The%20American%20heart%20journal&rft.au=Polo%C5%84ski,%20Lech&rft.date=2003-05-01&rft.volume=145&rft.issue=5&rft.spage=855&rft.epage=861&rft.pages=855-861&rft.issn=0002-8703&rft.eissn=1097-6744&rft.coden=AHJOA2&rft_id=info:doi/10.1016/S0002-8703(02)94823-4&rft_dat=%3Cproquest_cross%3E3237754241%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1504534033&rft_id=info:pmid/12766744&rft_els_id=S0002870302948234&rfr_iscdi=true